|
GFR (ml/min/1.73m2)
|
54.03 (12.81)
|
67.54 (6.45)
|
<0.001
|
|
Age (y)
|
64 (12.50)
|
63 (13.75)
|
0.154
|
|
Sex (Male/Female)
|
105/175
|
105/175
|
–
|
|
Duration of diabetes (y)
|
11.99 (6.4)
|
11.87 (4.72)
|
0.417
|
|
Body mass index (kg/m2)
|
28.72 (9.9)
|
28.47 (3.88)
|
0.554
|
|
Systolic blood pressure (mmHg)
|
13 (3)
|
13 (3)
|
0.203
|
|
Diastolic blood pressure (mmHg)
|
80 (18)
|
79 (20)
|
0.581
|
|
Use of anti-hypertensive drugs
|
157 (56.5%)
|
124 (44.9%)
|
0.057
|
|
Fasting plasma glucose (mg/dl)
|
143 (23)
|
136 (38)
|
0.078
|
|
2 h-PG (mg/dl)
|
227.16 ± 89.431
|
209.09 ± 91.73
|
0.896
|
|
Use of glucose-lowering drugs
|
201 (72.3%)
|
207 (74.7%)
|
0.510
|
|
Total cholesterol (mg/dl)
|
184 (59)
|
187.5 (41)
|
0.702
|
|
HDL cholesterol (mg/dl)
|
47 (12)
|
46 (20)
|
0.914
|
|
LDL cholesterol (mg/dl)
|
102.8 (49)
|
106.8 (43)
|
0.426
|
|
Triglyceride (mg/dl)
|
154.5 (124)
|
148 (127)
|
0.347
|
|
Use of lipid-lowering drugs
|
125 (45%)
|
112 (40.4%)
|
0.459
|
|
Creatinine (mg/dl)
|
1.2 (0)
|
1 (0)
|
<0.001
|
|
FRAP (μmol/L)
|
920 (252.5)
|
1045 (217.5)
|
<0.001
|
|
Current or pervious smoking
|
19 (6.8%)
|
14 (5%)
|
0.375
|
|
Hyperlipidemia
|
48 (17.1%)
|
47 (16.8%)
|
0.514
|
|
Hypertension
|
32 (11.4%)
|
48 (17.1%)
|
0.138
|
|
Obesity (BMI ≥ 30)
|
103 (36.8%)
|
104 (37.1%)
|
0.986
|
